A new lineage of effector CD4
+ T cells characterized by production of interleukin (IL)-17, the T-helper-17 (T
H17) lineage, was recently described based on developmental and functional features distinct from those of classical T
H1 and T
H2 lineages
1,2. Like T
H1 and T
H2, T
H17 cells almost certainly evolved to provide adaptive immunity tailored to specific classes of pathogens
3, such as extracellular bacteria
4. Aberrant T
H17 responses have been implicated in a growing list of autoimmune disorders
5,6,7. T
H17 development has been linked to IL-23, an IL-12 cytokine family member that shares with IL-12 a common subunit, IL-12p40 (ref. 8). The IL-23 and IL-12 receptors also share a subunit, IL-12Rβ1, that pairs with unique, inducible components, IL-23R and IL-12Rβ2, to confer receptor responsiveness
9. Here we identify transforming growth factor-β (TGF-β) as a cytokine critical for commitment to T
H17 development. TGF-β acts to upregulate IL-23R expression, thereby conferring responsiveness to IL-23. Although dispensable for the development of IL-17-producing T cells
in vitro and
in vivo, IL-23 is required for host protection against a bacterial pathogen,
Citrobacter rodentium. The action of TGF-β on naive T cells is antagonized by interferon-γ and IL-4, thus providing a mechanism for divergence of the T
H1, T
H2 and T
H17 lineages.